The History of Photodetection and Photodynamic Therapy¶
暂无分享,去创建一个
M. Reed | R. Ackroyd | Roger Ackroyd | Clive Kelty | Nicola Brown | Malcolm Reed | C. Kelty | N. Brown
[1] U. Pichlmeier,et al. No Generalized Skin Phototoxicity after Intravesical Application of 5-Aminolevulinic Acid for Fluorescence Diagnosis ofSuperficial Bladder Cancer , 2000, Urologia Internationalis.
[2] O J Balchum,et al. Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphvrin derivative , 1984, Lasers in surgery and medicine.
[3] H Kerl,et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. , 1997, Journal of photochemistry and photobiology. B, Biology.
[4] D. Vernon,et al. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. , 1993, Journal of photochemistry and photobiology. B, Biology.
[5] H Stepp,et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.
[6] Herbert Stepp,et al. Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy , 1999, European Urology.
[7] T. Dougherty,et al. Studies on the mechanism of tumor destruction by photoradiation therapy. , 1984, Progress in clinical and biological research.
[8] H. Pass,et al. Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.
[9] K. Schomacker,et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid , 1999, BJU international.
[10] D. Kessel,et al. Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients. , 1997, Journal of photochemistry and photobiology. B, Biology.
[11] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.
[12] U. Nseyo,et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. , 1998, The Journal of urology.
[13] M. Berns,et al. Laser photoradiation therapy of cancer: An update of the experience at the university of California, Irvine , 1984, Lasers in surgery and medicine.
[14] J. Spikes. The Historical Development of Ideas on Applications of Photosensitized Reactions in the Health Sciences , 1985 .
[15] M. Gray,et al. Hematoporphyrin derivative for detection and management of cancer , 1967, Cancer.
[16] W. Cheong,et al. Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy. , 2000, Circulation.
[17] J R Leonard,et al. Hematoporphyrin fluorescence: An aid in diagnosis of malignant neoplasms , 1971, The Laryngoscope.
[18] Manganiello Lo,et al. Studies on cancer detection and therapy; the affinity of neoplastic, embryonic, and traumatized tissue for porphyrins, metalloporphyrins, and radioactive zinc hematoporphyrin. , 1948 .
[19] T. Fitzpatrick,et al. Historical aspects of methoxsalen and other furocoumarins. , 1959, The Journal of investigative dermatology.
[20] V. Fingar,et al. Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[21] Daniel R. Doiron,et al. SnET2: clinical update , 1996, Photonics West.
[22] H. Kato,et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.
[23] T. Dougherty,et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. , 1998, The Annals of thoracic surgery.
[24] M. Berns,et al. Laser photoradiation therapy of cancer following hematoporphyrin sensitization , 1982, Lasers in surgery and medicine.
[25] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[26] M. Korbelik,et al. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. , 1999, Cancer letters.
[27] T. Dougherty. HEMATOPORPHYRIN AS A PHOTOSENSITIZER OF TUMORS * , 1983, Photochemistry and photobiology.
[28] H. Messmann. 5-Aminolevulinic acid-induced protoporphyrin IX for the detection of gastrointestinal dysplasia. , 2000, Gastrointestinal endoscopy clinics of North America.
[29] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[30] D. Ost. Photodynamic therapy in lung cancer. A review. , 2003, Methods in molecular medicine.
[31] Richard L. Lipson,et al. Transactions of the Ninetieth Annual Meeting of the American Gynecological Society—continuedUse of hematoporphyrin derivative in detection and management of cervical cancer: A preliminary report☆☆☆ , 1967 .
[32] E J BALDES,et al. The photodynamic properties of a particular hematoporphyrin derivative. , 1960, Archives of dermatology.
[33] T. Fitzpatrick,et al. Part IV: Basic Considerations of the Psoralens: Historical Aspects of Methoxsalen and Other Furocoumarins1 , 1959 .
[34] F. Figge,et al. Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[35] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[36] R Baumgartner,et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.
[37] J P Cooke,et al. Photoangioplasty for Human Peripheral Atherosclerosis: Results of a Phase I Trial of Photodynamic Therapy With Motexafin Lutetium (Antrin) , 2000, Circulation.
[38] A. Moor,et al. Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.
[39] A E Profio,et al. Laser fluorescence bronchoscope for localization of occult lung tumors. , 1979, Medical physics.
[40] D. Kessel,et al. Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.
[41] D. Drabkin. INTRODUCTION: SOME HISTORICAL HIGHLIGHTS IN KNOWLEDGE OF PORPHYRINS AND PORPHYRIAS , 1963 .
[42] T J Dougherty,et al. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.
[43] J. Potter,et al. Can Breast Carcinoma be Anticipated?: A Follow‐up of Benign Breast Biopsies , 1968, Annals of surgery.
[44] E J BALDES,et al. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. , 1961, The Journal of thoracic and cardiovascular surgery.
[45] E J BALDES,et al. The use of a derivative of hematoporhyrin in tumor detection. , 1961, Journal of the National Cancer Institute.
[46] B. Jarvis,et al. Topical Aminolevulinic Acid HCl Photodynamic Therapy , 2000, American journal of clinical dermatology.
[47] M. C. Berenbaum,et al. Photodynamic destruction of human bladder carcinoma. , 1975, British Journal of Cancer.
[48] M C Berenbaum,et al. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. , 1986, British Journal of Cancer.
[49] J Moan,et al. On the pharmacokinetics of topically applied 5‐aminolevulinic acid and two of its esters , 2001, International journal of cancer.
[50] F. Figge,et al. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin , 1955, Surgical forum.
[51] M. Korbelik,et al. Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[52] Christian Gluud,et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.
[53] B. Ward,et al. The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment. , 1982, American journal of obstetrics and gynecology.
[54] V. Schweitzer. Photodynamic therapy for treatment of head and neck cancer , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[55] M. Metzdorff,et al. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. , 1990, Chest.
[56] S. Granick. HEPATIC PORPHYRIA AND DRUG‐INDUCED OR CHEMICAL PORPHYRIA * , 1965, Annals of the New York Academy of Sciences.
[57] Joris Kloek,et al. Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.
[58] J C Kennedy,et al. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.
[59] T. Dougherty,et al. Lasers and hematoporphyrin derivative in cancer , 1983 .
[60] B. Overholt,et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. , 1995, Gastrointestinal endoscopy.
[61] H. C. Robertson,et al. Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.
[62] D. Doiron,et al. Dose measurements in photodynamic therapy of cancer , 1987, Lasers in surgery and medicine.
[63] B. Wilson,et al. Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. , 1996, Journal of clinical laser medicine & surgery.
[64] W. Morison. Phototherapy and photochemotherapy. , 1992, Advances in dermatology.
[65] C. Wilson,et al. Photodynamic therapy of malignant tumours. , 1972, Lancet.
[66] R Baumgartner,et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.
[67] N. Müller,et al. Predicting the response of obstructive endobronchial tumors to photodynamic therapy , 1986, Cancer.
[68] H. Kato,et al. Fiberoptic bronchoscopic laser photoradiation for tumor localization in lung cancer. , 1982, Chest.
[69] S. Bown,et al. The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. , 1991, The Journal of urology.
[70] D. Fraker,et al. Preliminary Report of Photodynamic Therapy for Intraperitoneal Sarcomatosis , 2001, Annals of Surgical Oncology.
[71] M. Snell,et al. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.
[72] T. Wieman,et al. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[73] F. Figge,et al. Cancer detection and therapy. II. Methods of preparation and biological effects of metallo-porphyrins. , 1951, Bulletin of the School of Medicine.
[74] F. Figge,et al. Use of hematoporphyrin fluorescence in biliary and cancer surgery. , 1955, The American surgeon.
[75] Alan R. Morgan,et al. The Diels-Alder reactions of protoporphyrin IX dimethyl ester with electron-deficient alkynes , 1986 .
[76] K. Berg,et al. THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.
[77] E. Reddi,et al. Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin. , 1984, Progress in clinical and biological research.
[78] J. Hill,et al. A history of photodynamic therapy. , 1991, The Australian and New Zealand journal of surgery.
[79] M. Biel. Photodynamic therapy and the treatment of head and neck neoplasia , 1998, The Laryngoscope.
[80] D. V. Ash,et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.
[81] A. M. Olsen,et al. The use of a derivative of hematoporphyrin in tumor detection. , 1961 .
[82] G. Stables,et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.
[83] Jos. Seherer. Chemisch‐physiologische Untersuchungen , 1841 .
[84] T J Dougherty,et al. The structure of the active component of hematoporphyrin derivative. , 1984, Progress in clinical and biological research.
[85] J. H. Kinsey,et al. Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. , 1983, The Journal of urology.
[86] A. Berner,et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.
[87] M. Kaplan,et al. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2) , 1998, Journal of surgical oncology.
[88] Chi-Wei Lin,et al. Photodynamic Therapy With Hematoporphyrin Derivative in the Treatment of Superficial Transitional-Cell Carcinoma of the Bladder , 1988 .
[89] B. Wilson,et al. Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.
[90] James S. McCaughan,et al. Palliation of esophageal malignancy with photoradiation therapy , 1984, Cancer.
[91] T. Okunaka,et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] J. Sessler,et al. Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy. , 2000, Biochemical pharmacology.
[93] H Stepp,et al. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. , 2001, The Journal of urology.
[94] J. H. Kinsey,et al. Detection of hematoporphyrin fluorescence during fiberoptic bronchoscopy to localize early bronchogenic carcinoma. , 1978, Mayo Clinic proceedings.
[95] H. Barr,et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.
[96] L. Gossner,et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. , 1998, Gastroenterology.
[97] E. Farrero,et al. Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction. , 1999, The European respiratory journal.
[98] J. H. Kinsey,et al. Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. , 1979, Mayo Clinic proceedings.
[99] P. Okunieff,et al. Phase I trial of photo dynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder , 1997 .
[100] C. Gomer,et al. Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors: examination of acute normal ocular tissue toxicity. , 1983, Cancer research.
[101] T. Weingeist,et al. Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. , 1984, Archives of ophthalmology.
[102] G. Elder. Haem Synthesis and the Porphyrias , 1994 .
[103] J. Feyh. Photodynamic treatment for cancers of the head and neck. , 1996, Journal of photochemistry and photobiology. B, Biology.
[104] H. Kato,et al. Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract. , 1985, Seminars in surgical oncology.
[105] Q. Peng,et al. Photodynamic Therapy , 1988, Methods in Molecular Biology.
[106] R. Anderson,et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. , 2000, The Journal of investigative dermatology.
[107] I. Stender,et al. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.
[108] T. Sutedja,et al. Photodynamic therapy in lung cancer. A review. , 1996, Journal of photochemistry and photobiology. B, Biology.
[109] M F Mafee,et al. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.
[110] S. Lam. Photodynamic therapy of lung cancer. , 1993, Thorax.
[111] D. Phillips,et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.
[112] Q. Peng,et al. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. , 1996, Ultrastructural pathology.
[113] L. Gossner,et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .
[114] C. Whitehurst,et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.
[115] M L Agarwal,et al. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. , 1991, Cancer research.
[116] T J Dougherty,et al. PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.
[117] P. Okunieff,et al. Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. , 1997, Urology.
[118] A H Kaye,et al. Selective uptake of hematoporphyrin derivative into human cerebral glioma. , 1990, Neurosurgery.
[119] A. Jaakkola,et al. [Photodynamic therapy of age-related macular degeneration]. , 2002, Duodecim; laaketieteellinen aikakauskirja.
[120] N. J. Brown,et al. MATERIALS AND METHODS Cell lines Human umbilical vein endothelial cells , 2022 .
[121] J E Kaufman,et al. Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.
[122] W. Star,et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.
[123] P. D. Smith,et al. Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. , 1986, British Journal of Cancer.
[124] K. Ghiggino,et al. EFFECTS OF TRYPTOPHAN OXIDATION ON BACTERIORHODOPSIN STRUCTURE AND FUNCTION , 1984 .
[125] D. Kessel,et al. CHEMISTRY OF HEMATOPORPHYRIN‐DERIVED PHOTOSENSITIZERS , 1987, Photochemistry and photobiology.
[126] D. Ladner,et al. Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid , 2001, British Journal of Cancer.
[127] Thomas J. Dougherty,et al. Basic principles of photodynamic therapy , 2001 .
[128] J. Sessler,et al. Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble Photosensitizer , 1996, Photochemistry and photobiology.
[129] R. Lipson,et al. Hematoporphyrin-derivative-fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia, and carcinoma in situ of the cervix uteri. , 1973, American journal of obstetrics and gynecology.
[130] D. Ash,et al. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.
[131] H. Barr,et al. Photodynamic therapy for colorectal cancer: A quantitative pilot study , 1990, The British journal of surgery.
[132] M J Gray,et al. Use of hematoporphyrin derivative in detection and management of cervical cancer. , 1967, American journal of obstetrics and gynecology.
[133] A. J. MacRobert,et al. Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. , 1998, British Journal of Cancer.
[134] D. Phillips,et al. EHPnet: Doing a World of Good , 1998, Environmental Health Perspectives.
[135] M T Tseng,et al. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. , 1989, Radiation research.
[136] D. Cortese,et al. Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. , 1984, Chest.
[137] R. Lambert,et al. Long-term survival after photodynamic therapy for esophageal cancer. , 1995, Gastroenterology.
[138] J C Kennedy,et al. NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.
[139] T J Dougherty,et al. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. , 1975, Journal of the National Cancer Institute.
[140] T. Mang,et al. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. , 1998, The cancer journal from Scientific American.
[141] T. Stephenson,et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.